Literature DB >> 2942603

The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs.

E C Böttger, T Hoffmann, S Metzger, U Hadding, D Bitter-Suermann.   

Abstract

The cobra venom factor (CVF)-mediated suppression of the humoral immune response to bacteriophage phi X 174, a T cell-dependent antigen, was investigated in guinea pigs. The suppression was markedly dependent on the amount of antigen used: decomplementation of animals diminished the humoral immune response when immunizing with low doses of antigen, whereas increasing the antigenic dose resulted in little or no diminution by CVF. In contrast to the results with normal animals, CVF had no influence on the humoral immune response of genetically C2-deficient guinea pigs; i.e., no suppression occurred above that due to the inherited complement deficiency state alone. We therefore postulate that CVF suppresses the humoral immune response by the depletion of C3, with no measurable role for complement split products under these experimental conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942603

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

Review 1.  Functions of antibodies in the regulation of B cell responses in vivo.

Authors:  B Heyman
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 2.  Evolution of complement as an effector system in innate and adaptive immunity.

Authors:  J Oriol Sunyer; Hani Boshra; Gema Lorenzo; David Parra; Bruce Freedman; Nina Bosch
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

3.  Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.

Authors:  J Arvieux; H Yssel; M G Colomb
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

4.  An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

Authors:  M A Hazlewood; D S Kumararatne; A D Webster; M Goodall; P Bird; M Daha
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Complement activation is required for IgM-mediated enhancement of the antibody response.

Authors:  B Heyman; L Pilström; M J Shulman
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

6.  In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody.

Authors:  B Heyman; E J Wiersma; T Kinoshita
Journal:  J Exp Med       Date:  1990-08-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.